NCT04560933View on ClinicalTrials.gov

A Study to Evaluate Seroprevalence and Seroconversion of Antibodies to Adeno-Associated Virus (AAV) in Patients With Hemophilia A

CompletedOBSERVATIONAL
Enrollment

186

Participants

Timeline

Start Date

August 25, 2020

Primary Completion Date

September 20, 2023

Study Completion Date

October 20, 2023

Conditions
Hemophilia A
Interventions
PROCEDURE

Blood sample collection

Blood sample collection

Trial Locations (1)

53704

Covance Inc, Madison

Sponsors
All Listed Sponsors
lead

BioMarin Pharmaceutical

INDUSTRY